Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03739710
Title Phase II Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Non-small Cell Lung Cancer (NSCLC)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors GlaxoSmithKline
Indications

lung non-small cell carcinoma

Therapies

Docetaxel

Docetaxel + GSK3359609

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU | CAN

Facility Status City State Zip Country Details
GSK Investigational Site Recruiting Los Angeles California 90025 United States Details
GSK Investigational Site Completed Saint Louis Missouri 63110-1093 United States Details
GSK Investigational Site Recruiting Bronx New York 10461-2375 United States Details
GSK Investigational Site Recruiting Bronx New York 10467 United States Details
GSK Investigational Site Completed Pinehurst North Carolina 28374 United States Details
GSK Investigational Site Recruiting Chattanooga Tennessee 37404 United States Details
GSK Investigational Site Recruiting Nashville Tennessee 37203 United States Details
GSK Investigational Site Completed Dallas Texas 75230 United States Details
GSK Investigational Site Recruiting Edmonton Alberta T6G 1Z2 Canada Details
GSK Investigational Site Recruiting Brampton Ontario L6R 3J7 Canada Details
GSK Investigational Site Recruiting Toronto Ontario M5G 2M9 Canada Details
GSK Investigational Site Recruiting Bordeaux Cedex 33076 France Details
GSK Investigational Site Recruiting Caen Cedex 9 14033 France Details
GSK Investigational Site Completed Nantes cedex 1 44093 France Details
GSK Investigational Site Recruiting Paris Cedex 05 75248 France Details
GSK Investigational Site Recruiting Paris 75018 France Details
GSK Investigational Site Recruiting Villejuif Cedex 94805 France Details
GSK Investigational Site Completed Heidelberg Baden-Wuerttemberg 69126 Germany Details
GSK Investigational Site Completed Gauting Bayern 82131 Germany Details
GSK Investigational Site Completed Immenhausen Hessen 34376 Germany Details
GSK Investigational Site Completed Kassel Hessen 34125 Germany Details
GSK Investigational Site Completed Leipzig Sachsen 04357 Germany Details
GSK Investigational Site Recruiting Grosshansdorf Schleswig-Holstein 22927 Germany Details
GSK Investigational Site Completed Berlin 14165 Germany Details
GSK Investigational Site Completed Napoli Campania 80131 Italy Details
GSK Investigational Site Recruiting Meldola (FC) Emilia-Romagna 47014 Italy Details
GSK Investigational Site Recruiting Ravenna Emilia-Romagna 48121 Italy Details
GSK Investigational Site Recruiting Milano Lombardia 20133 Italy Details
GSK Investigational Site Completed Orbassano (TO) Piemonte 10043 Italy Details
GSK Investigational Site Recruiting Siena Toscana 53100 Italy Details
GSK Investigational Site Completed Cheongju-si, Chungcheongbuk-do 28644 Korea, Republic of Details
GSK Investigational Site Completed Gyeonggi-do 10408 Korea, Republic of Details
GSK Investigational Site Completed Seongnam 13620 Korea, Republic of Details
GSK Investigational Site Completed Seoul 05505 Korea, Republic of Details
GSK Investigational Site Completed Amsterdam 1081 HV Netherlands Details
GSK Investigational Site Completed Maastricht 6229 HX Netherlands Details
GSK Investigational Site Recruiting Konin 62-500 Poland Details
GSK Investigational Site Completed Lodz 93-513 Poland Details
GSK Investigational Site Completed Poznan 60-569 Poland Details
GSK Investigational Site Completed Warszawa 02-781 Poland Details
GSK Investigational Site Completed Bucharest 020142 Romania Details
GSK Investigational Site Completed Craiova 200347 Romania Details
GSK Investigational Site Completed Floresti 407280 Romania Details
GSK Investigational Site Completed Otopeni 075100 Romania Details
GSK Investigational Site Completed Timisoara 300166 Romania Details
GSK Investigational Site Completed Chelyabinsk 454048 Russian Federation Details
GSK Investigational Site Completed Saint-Petersburg 194291 Russian Federation Details
GSK Investigational Site Completed Saint-Petersburg 197183 Russian Federation Details
GSK Investigational Site Completed Badajoz 06080 Spain Details
GSK Investigational Site Recruiting Barcelona 08035 Spain Details
GSK Investigational Site Recruiting Barcelona 08036 Spain Details
GSK Investigational Site Completed Madrid 28027 Spain Details
GSK Investigational Site Completed Madrid 28033 Spain Details
GSK Investigational Site Recruiting Madrid 28034 Spain Details
GSK Investigational Site Recruiting Málaga 29010 Spain Details
GSK Investigational Site Recruiting Santander 39008 Spain Details
GSK Investigational Site Completed Sevilla 41009 Spain Details
GSK Investigational Site Completed Solna SE-171 64 Sweden Details
GSK Investigational Site Completed Uppsala SE- 75 185 Sweden Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field